Your browser doesn't support javascript.
loading
Type-I protein arginine methyltransferase inhibition primes anti-programmed cell death protein 1 immunotherapy in triple-negative breast cancer.
Zhang, Sheyu; Guo, Lu; Zhang, Ziwen; Liu, Xueying; Chen, Wenjun; Wei, Yong; Wang, Xiaojia; Wu, Qin.
Afiliación
  • Zhang S; School of Life Sciences, Tianjin University, Tianjin, China.
  • Guo L; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Zhang Z; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Liu X; Department of Medical Oncology (Breast Cancer), Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
  • Chen W; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Wei Y; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Wang X; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Wu Q; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
Cancer ; 130(S8): 1415-1423, 2024 Apr 15.
Article en En | MEDLINE | ID: mdl-38079306
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Animals / Humans Idioma: En Revista: Cancer Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Animals / Humans Idioma: En Revista: Cancer Año: 2024 Tipo del documento: Article País de afiliación: China